With 0.88 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.39 million shares. The 52-week range on ADTX shows that it touched its highest point at $76.40 and its lowest point at $2.95 during that stretch. It currently has a 1-year price target of $3.70. Beta for the stock currently stands at 1.01.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ADTX was down-trending over the past week, with a drop of -0.48%, but this was down by -11.46% over a month. Three-month performance dropped to -35.63% while six-month performance fell -74.12%. The stock lost -91.52% in the past year, while it has lost -53.39% so far this year.
Float and Shares Shorts:
At present, 1.96 million ADTX shares are outstanding with a float of 1.96 million shares on hand for trading. On Mar 15, 2024, short shares totaled 35050.0, which was 2.10% higher than short shares on Feb 15, 2024. In addition to CDTX as the firm’s Cidara Therapeutics, Inc., AMTX serves as its Aemetis, Inc.
Institutional Ownership:
Through their ownership of 6.06% of ADTX’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ADTX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
Dividends & Yield:
In terms of dividends, ADTX has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and ADTX currently yields $0.00. In the past year, ADTX’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, ADTX has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.
